An open-label pilot trial of faecal microbiome transfer to restore the gut microbiome in anorexia nervosa: protocol

被引:2
|
作者
Wilson, Brooke C. [1 ]
Derraik, Jose G. B. [1 ,2 ]
Albert, Benjamin B. [1 ]
Leong, Karen S. W. [1 ]
Tweedie-Cullen, Ry Y. [1 ]
Creagh, Christine [1 ]
Depczynski, Marysia [1 ]
Edwards, Taygen [1 ]
Vatanen, Tommi [1 ,3 ]
Thabrew, Hiran [4 ,5 ]
Cutfield, Wayne S. [1 ]
O'Sullivan, Justin M. [1 ]
机构
[1] Univ Auckland, Liggins Inst, Auckland, New Zealand
[2] Univ Auckland, Fac Med & Hlth Sci, Dept Paediat Child & Youth Hlth, Auckland, New Zealand
[3] Univ Helsinki, Helsinki Inst Life Sci, Helsinki, Finland
[4] Univ Auckland, Dept Psychol Med, Auckland, New Zealand
[5] Univ Auckland, Ctr Infant Child & Adolescent Mental Hlth, Te Ara Haro, Auckland, New Zealand
来源
BMJ OPEN | 2023年 / 13卷 / 07期
关键词
eating disorders; microbiology; therapeutics; transplant medicine; gastroenterology; INTESTINAL MICROBIOTA; INSULIN SENSITIVITY; EATING-DISORDERS; TRANSPLANTATION; ANXIETY; PERMEABILITY; INDIVIDUALS; DEPRESSION;
D O I
10.1136/bmjopen-2022-070616
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionIndividuals with anorexia nervosa (AN) harbour distinct gut microbiomes compared with healthy individuals, which are sufficient to induce weight loss and anxiety-like behaviours when transplanted into germ-free mice. We hypothesise that faecal microbiome transfer (FMT) from healthy donors would help restore the gut microbiome of individuals with AN, which in turn, may aid patient recovery. MethodsWe aim to conduct an open-label pilot study in 20 females aged 16-32 years in Auckland, New Zealand who meet the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5) criteria for AN and have a body mass index 13-19 kg/m(2). We will recruit four healthy, lean, female donors, aged 18-32 years, who will undergo extensive clinical screening prior to stool donation. Faecal microbiota will be harvested from donors and double encapsulated in delayed release, acid-resistant capsules. All participants will receive a single course of 20 FMT capsules (five from each donor) which they can choose to take over two or four consecutive days. Stool and blood samples will be collected from participants over a period of 3 months to assess their gut microbiome profile, metabolome, levels of intestinal inflammation and nutritional status. Our primary outcome is a shift in the gut microbiome composition at 3 weeks post-FMT (Bray-Curtis dissimilarity). We will also monitor participants' body composition (whole-body dual-energy X-ray absorptiometry scans), eating disorder psychopathology, mental health and assess their views on, and tolerability of, treatment. All adverse events will be recorded and reviewed by an independent data monitoring committee. Ethics and disseminationEthics approval was provided by the Central Health and Disability Ethics Committee (Ministry of Health, New Zealand, 21/CEN/212). Results will be published in peer-reviewed journals and presented to both scientific and consumer group audiences.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Rofecoxib in the prevention of perimenstrual migraine: An open-label pilot trial
    Von Seggern, RL
    Mannix, LK
    Adelman, JU
    HEADACHE, 2004, 44 (02): : 160 - 165
  • [42] Effect of aspirin on gut microbiome in a pilot randomized double-blind trial
    Prizment, Anna E.
    Menk, Jeremiah
    Staley, Christopher
    Vivek, Sithara
    Onyeaghala, Guillaume
    Thyagarajan, Bharat
    Demmer, Ryan
    Knights, Dan
    Meyer, Kathie
    Shaukat, Aasma
    Khorutz, Alexander
    Sadowsky, Michael J.
    Straka, Robert J.
    Church, Timothy
    CANCER RESEARCH, 2019, 79 (13)
  • [43] The Gut Microbiome Derived From Anorexia Nervosa Patients Impairs Weight Gain and Behavioral Performance in Female Mice
    Hata, Tomokazu
    Miyata, Noriyuki
    Takakura, Shu
    Yoshihara, Kazufumi
    Asano, Yasunari
    Kimura-Todani, Tae
    Yamashita, Makoto
    Zhang, Xue-Ting
    Watanabe, Natsuru
    Mikami, Katsunaka
    Koga, Yasuhiro
    Sudo, Nobuyuki
    ENDOCRINOLOGY, 2019, 160 (10) : 2441 - 2452
  • [44] Food matters: how the microbiome and gut-brain interaction might impact the development and course of anorexia nervosa
    Herpertz-Dahlmann, Beate
    Seitz, Jochen
    Baines, John
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2017, 26 (09) : 1031 - 1041
  • [45] Anorexia nervosa-specific home treatment in children and adolescents and their families (the HoT study): a study protocol of a randomized, controlled, multicenter, open-label, parallel group superiority trial
    Brigitte Dahmen
    Ingar Zielinski-Gussen
    Manuel Föcker
    Freia Hahn
    Tanja Legenbauer
    Ulf Thiemann
    Astrid Dempfle
    Beate Herpertz-Dahlmann
    Trials, 25 (1)
  • [46] Darmmikrobiom und Anorexia nervosaDer Zusammenhang von Mikrobiom und Darm-Gehirn-Interaktion im Kontext der Anorexia nervosaGut microbiome and anorexia nervosaThe relationship between microbiome and gut-brain interaction in the context of anorexia nervosa
    J. Seitz
    L. Keller
    S. Trinh
    B. Herpertz-Dahlmann
    Der Nervenarzt, 2020, 91 : 1115 - 1121
  • [47] An open-label pilot trial of minocycline in children as a treatment for Angelman syndrome
    Grieco, Joseph C.
    Ciarlone, Stephanie L.
    Gieron-Korthals, Maria
    Schoenberg, Mike R.
    Smith, Amanda G.
    Philpot, Rex M.
    Heussler, Helen S.
    Banko, Jessica L.
    Weeber, Edwin J.
    BMC NEUROLOGY, 2014, 14
  • [48] A pilot open-label trial of minocycline in patients with autism and regressive features
    Carlos A Pardo
    Ashura Buckley
    Audrey Thurm
    Li-Ching Lee
    Arun Azhagiri
    David M Neville
    Susan E Swedo
    Journal of Neurodevelopmental Disorders, 2013, 5
  • [49] A pilot open-label trial of minocycline in patients with autism and regressive features
    Pardo, Carlos A.
    Buckley, Ashura
    Thurm, Audrey
    Lee, Li-Ching
    Azhagiri, Arun
    Neville, David M.
    Swedo, Susan E.
    JOURNAL OF NEURODEVELOPMENTAL DISORDERS, 2013, 5 : 1 - 9
  • [50] A Pilot Open-Label Trial of Zonisamide in Unverricht-Lundborg Disease
    Italiano, Domenico
    Pezzella, Marianna
    Coppola, Antonietta
    Magaudda, Adriana
    Ferlazzo, Edoardo
    Bramanti, Placido
    Striano, Salvatore
    Zara, Federico
    Striano, Pasquale
    MOVEMENT DISORDERS, 2011, 26 (02) : 341 - 343